Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats

Drug Metabolism and Pharmacokinetics

Volumn 27, Issue 2, 2012, Pages 242-247

  Egashira, Kanoko ^a,b   Sasaki, Hitoshi ^a   Higuchi, Shun ^c   Ieiri, Ichiro ^b  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

CYP3A; Food drug interaction; Ginger; Pharmacokinetics; Pomelo; Tacrolimus; Turmeric

Indexed keywords

CYTOCHROME P450 3A; TACROLIMUS; TURMERIC;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; ENZYME ACTIVITY; FOOD DRUG INTERACTION; FRUIT JUICE; GINGER; GINGER JUICE; GRAPEFRUIT JUICE; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; POMELO JUICE; PUMMELO; RAT; REPEATED DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TURMERIC JUICE;

EID: 84860306749     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-RG-105     Document Type: Article

References (36)

1. Spencer, C. M., Goa, K. L. and Gillis, J. C.: Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs, 54: 925-975 (1997).
2. Venkataramanan, R., Swaminathan, A., Prasad, T., Jain, A., Zuckerman, S., Warty, V., McMichael, J., Lever, J., Burckart, G. and Starzl, T.: Clinical pharmacokinetics of tacrolimus. Clin. Pharmacokinet., 29: 404-430 (1995).
3. Vincent, S. H., Karanam, B. V., Painter, S. K. and Chiu, S. H.: In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch. Biochem. Biophys., 294: 454-460 (1992).
4. Kamdem, L. K., Streit, F., Zanger, U. M., Brockmöller, J., Oellerich, M., Armstrong, V. W. and Wojnowski, L.: Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. Clin. Chem., 51: 1374-1381 (2005).
5. Shiraga, T., Matsuda, H., Nagase, K., Iwasaki, K., Noda, K., Yamazaki, H., Shimada, T. and Funae, Y.: Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochem. Pharmacol., 47: 727-735 (1994).
6. Lampen, A., Christians, U., Guengerich, F. P., Watkins, P. B., Kolars, J. C., Bader, A., Gonschior, A. K., Dralle, H., Hackbarth, I. and Sewing, K. F.: Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab. Dispos., 23: 1315-1324 (1995).
7. Saeki, T., Ueda, K., Tanigawara, Y., Hori, R. and Komano, T.: Human P-glycoprotein transports cyclosporin A and FK506. J. Biol. Chem., 268: 6077-6080 (1993).
8. Vasquez, E. M., Shin, G. P., Sifontis, N. and Benedetti, E.: Concomitant clotrimazole therapy more than doubles the relative oral bioavailability of tacrolimus. Ther. Drug Monit., 27: 587-591 (2005).
9. Vasquez, E. M., Pollak, R. and Benedetti, E.: Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients. Clin. Transplant., 15: 95-99 (2001).
10. Egashira, K., Fukuda, E., Onga, T., Yogi, Y., Matsuya, F., Koyabu, N., Ohtani, H. and Sawada, Y.: Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation, 75: 1057 (2003).
11. Egashira, K., Ohtani, H., Itoh, S., Koyabu, N., Tsujimoto, M., Murakami, H. and Sawada, Y.: Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab. Dispos., 32: 828-833 (2004).
12. Kimura, Y., Ito, H. and Hatano, T.: Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity. Biol. Pharm. Bull., 33: 1977-1982 (2010).
13. Yamaoka, K. and Nakagawa, T.: A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J. Pharmacobiodyn., 6: 595-606 (1983).
14. Yamaoka, K., Nakagawa, T. and Uno, T.: Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm., 6: 547-558 (1978).
15. Greenblatt, D. J., von Moltke, L. L., Harmatz, J. S., Chen, G., Weemhoff, J. L., Jen, C., Kelley, C. J., LeDuc, B. W. and Zinny, M. A.: Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice. Clin. Pharmacol. Ther., 74: 121-129 (2003).
16. Bailey, D. G., Spence, J. D., Munoz, C. and Arnold, J. M.: Interaction of citrus juices with felodipine and nifedipine. Lancet, 337: 268-269 (1991).
17. Uno, T., Ohkubo, T., Sugawara, K., Higashiyama, A., Motomura, S. and Ishizaki, T.: Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site. Eur. J. Clin. Pharmacol., 56: 643-649 (2000).
18. Lilja, J. J., Kivistö, K. T. and Neuvonen, P. J.: Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin. Clin. Pharmacol. Ther., 68: 384-390 (2000).
19. Ando, H., Tsuruoka, S., Yanagihara, H., Sugimoto, K., Miyata, M., Yamazoe, Y., Takamura, T., Kaneko, S. and Fujimura, A.: Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin. Br. J. Clin. Pharmacol., 60: 494-497 (2005).
20. Kanazawa, S., Ohkubo, T. and Sugawara, K.: The effects of grapefruit juice on the pharmacokinetics of erythromycin. Eur. J. Clin. Pharmacol., 56: 799-803 (2001).
21. Kupferschmidt, H. H., Fattinger, K. E., Ha, H. R., Follath, F. and Krähenbühl, S.: Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br. J. Clin. Pharmacol., 45: 355-359 (1998).
22. Liu, C., Shang, Y. F., Zhang, X. F., Zhang, X. G., Wang, B., Wu, Z., Liu, X. M., Yu, L., Ma, F. and Lv, Y.: Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study. Eur. J. Clin. Pharmacol., 65: 881-885 (2009).
23. Ducharme, M. P., Warbasse, L. H. and Edwards, D. J.: Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther., 57: 485-491 (1995).
24. Takanaga, H., Ohnishi, A., Matsuo, H. and Sawada, Y.: Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol. Pharm. Bull., 21: 1062-1066 (1998).
25. Ohnishi, A., Matsuo, H., Yamada, S., Takanaga, H., Morimoto, S., Shoyama, Y., Ohtani, H. and Sawada, Y.: Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br. J. Pharmacol., 130: 1369-1377 (2000).
26. Lundahl, J., Regårdh, C. G., Edgar, B. and Johnsson, G.: Effects of grapefruit juice ingestion-pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur. J. Clin. Pharmacol., 52: 139-145 (1997).
27. Bailey, D. G., Malcolm, J., Arnold, O. and Spence, J. D.: Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol., 46: 101-110 (1998).
28. Guo, L. Q., Fukuda, K., Ohta, T. and Yamazoe, Y.: Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab. Dispos., 28: 766-771 (2000).
29. Edwards, D. J., Bellevue, F. H., 3rd and Woster, P. M.: Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab. Dispos., 24: 1287-1290 (1996).
30. Makino, T., Mizuno, F. and Mizukami, H.: Does a kampo medicine containing schisandra fruit affect pharmacokinetics of nifedipine like grapefruit juice? Biol. Pharm. Bull., 29: 2065-2069 (2006).
31. Vutyavanich, T., Kraisarin, T. and Ruangsri, R.: Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebocontrolled trial. Obstet. Gynecol., 97: 577-582 (2001).
32. Lien, H. C., Sun, W. M., Chen, Y. H., Kim, H., Hasler, W. and Owyang, C.: Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am. J. Physiol. Gastrointest. Liver Physiol., 284: G481-G489 (2003).
33. Anuchapreeda, S., Leechanachai, P., Smith, M. M., Ambudkar, S. V. and Limtrakul, P. N.: Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol., 64: 573-582 (2002).
34. Zhang, W. and Lim, L. Y.: Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab. Dispos., 36: 1283-1290 (2008).
35. Zhang, W., Tan, T. M. and Lim, L. Y.: Impact of curcumininduced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab. Dispos., 35: 110-115 (2007).
36. Tata, P. N., Subbotina, N., Burckart, G. J., Muddiman, D. C., Gusev, A. I., Hercules, D. M., Starzl, T. E. and Venkataramanan, R.: Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). Xenobiotica, 39: 757-765 (2009).